三点悬吊折叠式人工晶状体植入术的临床应用

Implantation of foldable intraocular lens fixed by three-point

目的研究三点悬吊折叠式人工晶状体植入的临床效果。方法应用三点悬吊固定植入XLSTABI—SKY三襻型折叠式人工晶状体60例。其中一期植入42例，二期植人18例。随访8个月。结果1例马凡综合症术后视力0．05，其余59眼视力0．2～1．0，平均视力（0．53±0．39）。平均屈光度：球镜：（-2．37±1．35）D。柱镜：（-1．21±2．38）D，随访期间，未见人工晶状体发生脱位、偏心等。无角膜内皮失代偿或眼内炎等严重并发症；结论三点悬吊折叠式人工晶状体植人术后视力提高明显，人工晶状体稳定，散光小，安全性好。

Objective To study the therapeutic efficacy of foldable intraocular lens fixed by three points for non - posterior - capsular aphakia. Methods XLSTABI - SKY intraocular lens （ Zeiss Company） fixed by three points were used for 60 patients who were aphakia with non-posterior-capsule or less capsule supporting intraocular lens. Complications and visual acuity were observed for 8 months. Results There was no significant complication in the operation. Except one patient with Mar＇fan＇s syndrome, 59 patients＇ visual acuities were between 0.2 - 1.0 at 8 months after the operation, and all patients＇ refraction error was （ -2.37 4±1.35）D of sph. and （ -1.21 4±2.38）D of cyl. No decentration or displacement of intraocular lens were observed. Conclusion XLSTABI-SKY foldable intraocular lens fixed by three points is a good choice for patients with aphakia.